1-(2-丙烯氧基)-2-萘甲酸 | 1009813-71-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 1-(2-丙烯氧基)-2-萘甲酸
• 英文名称: 1-allyloxy-2-naphthoic acid
• 英文别名: 1-Prop-2-enoxynaphthalene-2-carboxylic acid
• CAS: 1009813-71-1
• 化学式: C₁₄H₁₂O₃
• mdl: MFCD13200471
• 分子量: 228.247
• InChiKey: KCYHQSYCDYONDA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.071
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(2-丙烯氧基)-2-萘甲酸 在 silver(I) acetate 作用下， 以 二甲基亚砜 为溶剂， 反应 18.0h， 以50%的产率得到2-ethenyl-4H-naphtho[1,2-d][1,3]dioxin-4-one
  参考文献：
  名称：

  Oxidative cyclization of alkenoic acids promoted by AgOAc

  摘要：

  从水杨酸类似物中衍生的烯酸经过AgOAc触发的意外氧化环化过程，导致4H-苯并[1,3]二噁烷-4-酮的形成。

  DOI：

  10.1039/c5dt03808a
• 作为产物：
  描述：

  1-羟基-2-萘甲酸 在 氯化亚砜 、 potassium carbonate 、 potassium hydroxide 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 92.0h， 生成 1-(2-丙烯氧基)-2-萘甲酸
  参考文献：
  名称：

  Oxidative cyclization of alkenoic acids promoted by AgOAc

  摘要：

  从水杨酸类似物中衍生的烯酸经过AgOAc触发的意外氧化环化过程，导致4H-苯并[1,3]二噁烷-4-酮的形成。

  DOI：

  10.1039/c5dt03808a

文献信息

• Synthesis of Novel C 2-Symmetric Sulfur-Based Catalysts: Asymmetric Formation of Halo- and Seleno-Functionalized Normal- and Medium-Sized Rings
  作者：Sadhan Jana、Ajay Verma、Vandana Rathore、Sangit Kumar

  DOI：10.1055/s-0037-1610715

  日期：2019.9

  The synthesis of novel, highly functionalized, C 2-symmetric sulfur-based catalysts is developed and their catalytic applications are explored in asymmetric bromo-, iodo- and seleno-functionalizations of alkenoic acids. This protocol provides the corresponding normal- and medium-sized bromo, iodo and selenolactones in up to 98% yield and 83% stereoselectivity.

  开发了新型、高度官能化的 C 2 对称硫基催化剂的合成，并探索了它们在烯酸的不对称溴、碘和硒官能化中的催化应用。该方案以高达 98% 的产率和 83% 的立体选择性提供相应的正常和中等大小的溴、碘和硒内酯。
• Organoselenium and DMAP co-catalysis: regioselective synthesis of medium-sized halolactones and bromooxepanes from unactivated alkenes
  作者：Ajay Verma、Sadhan Jana、Ch. Durga Prasad、Abhimanyu Yadav、Sangit Kumar

  DOI：10.1039/c5cc10245f

  日期：——

  A catalytic system consisting of bis(4-methoxyphenyl)selenide and 4-(dimethylamino)pyridine (DMAP) has been developed for the regioselective synthesis of medium-sized bromo/iodo lactones and bromooxepanes possessing high transannular strain. 77Se NMR, mass spectrometry...

  已经开发了由双（4-甲氧基苯基）硒化物和4-（二甲基氨基）吡啶（DMAP）组成的催化体系，用于区域选择性合成具有高跨环应变的中型溴/碘内酯和溴氧杂环丁烷。77Se NMR，质谱...
• ENHANCED ANTI-INFLUENZA AGENTS CONJUGATED WITH ANTI-INFLAMMATORY ACTIVITY
  申请人：ACADEMIA SINICA

  公开号：US20130274229A1

  公开（公告）日：2013-10-17

  Novel dual-targeted, bifunctional anti-influenza drugs formed by conjugation with anti-inflammatory agents are disclosed. Exemplary drugs according to the invention include caffeic acid (CA)-bearing zanamivir (ZA) conjugates ZA-7-CA (1), ZA-7-CA-amide (7) and ZA-7-Nap (43) for simultaneous inhibition of influenza virus neuraminidase and suppression of proinflammatory cytokines. Synthetic methods for preparation of these enhanced anti-influenza conjugate drugs are provided. The synthetic bifunctional ZA conjugates act synergistically towards protection of mice lethally infected by H1N1 or H5N1 influenza viruses. The efficacy of ZA-7-CA, ZA-7-CA-amide and ZA-7-Nap conjugates is much greater than the combination therapy of ZA with anti-inflammatory agents.

  新型双靶向、双功能抗流感药物通过与抗炎药物结合形成。根据本发明的示例药物包括咖啡酸（CA）基底的扎那米韦（ZA）共轭物ZA-7-CA（1）、ZA-7-CA酰胺（7）和ZA-7-Nap（43），用于同时抑制流感病毒神经氨基酸酶和抑制促炎细胞因子。提供了用于制备这些增强型抗流感共轭药物的合成方法。合成的双功能ZA共轭物对保护由H1N1或H5N1流感病毒致命感染的小鼠具有协同作用。ZA-7-CA、ZA-7-CA酰胺和ZA-7-Nap共轭物的疗效远远优于ZA与抗炎药物的联合治疗。
• Novel substituted naphthalene compounds and liquid crystal compositions containing same
  申请人：MITSUI PETROCHEMICAL INDUSTRIES, LTD.

  公开号：EP0332409A2

  公开（公告）日：1989-09-13

  In accordance with the present invention, there are provided substituted naphthalene compounds of formula [I]. wherein R¹ represents alkyl of 1-18 carbon atoms, R² represents alkyl of 1-18 carbon atoms, X is -OCH₂- or -CH₂CH₂-, and n is 0 or 1. The invention also provides liquid crystal compositions containing a substituted naphthalene compound such as a compound of formula [I].

  根据本发明，提供了式[I]的取代萘化合物。 其中 R¹ 代表 1-18 个碳原子的烷基，R² 代表 1-18 个碳原子的烷基，X 为 -OCH₂- 或 -CH₂CH₂-，n 为 0 或 1。 本发明还提供了含有取代萘化合物（如式 [I] 的化合物）的液晶组合物。
• Enhanced Anti-influenza Agents Conjugated with Anti-inflammatory Activity
  作者：Kung-Cheng Liu、Jim-Min Fang、Jia-Tsrong Jan、Ting-Jen R. Cheng、Shi-Yun Wang、Shi-Ting Yang、Yih-Shyun E. Cheng、Chi-Huey Wong

  DOI：10.1021/jm3009844

  日期：2012.10.11

  Influenza therapy with a single targeted compound is often limited in efficacy due to the rapidly developed drug resistance. Moreover, the uncontrolled virus-induced cytokines could cause the high mortality of human infected by H5N1 avian influenza virus. In this study, we explored the novel dual-targeted bifunctional anti-influenza drugs formed by conjugation with anti-inflammatory agents. In particular, the caffeic acid (CA)-bearing zanamivir (ZA) conjugates ZA-7-CA (1) and ZA-7-CA-amide (7) showed simultaneous inhibition of influenza virus neuraminidase and suppression of pro-inflammatory cytokines. These ZA conjugates provided remarkable protection of cells and mice against influenza infections. Intranasal administration of low dosage (<1.2 mu mol/kg/day) of ZA conjugates exhibited much greater effect than the combination therapy with ZA and the anti-inflammatory agents in protection of the lethally infected mice by H1N1 or H5N1 influenza viruses.